OEL Fastrac Catalog

Olive oil is composed of two fractions, the saponifiable fraction and the nonsaponifiable fraction. The saponifiable fraction constitutes 98% to 99% of the oil by weight and contains most of the fatty acids; 80% of these are the monounsaturated fatty acid (MUFC) and oleic acid. Other acids are also present, albeit, in much smaller quantities. These include stearic, palmitic, linoleic, and α-linoleic acids. The nonsaponifiable fraction contains the minor constituents of olive oil and includes many different compounds including phenols, sterols, hydrocarbons, pigments, volatile compounds, aliphatic compounds, and esters including waxes and pigments such as chlorophylls and tocopherols. There are a number of hydrocarbons present in olive oil, including phenanthrene, perylene, chrysene, and pyrene, although the most abundant is squalene, from which sterols are biosynthesized. Sterol tetracyclines are a subgroup of steroids, and those found in olive oil include β-sitosterol, stigmasterol, and campesterol.

Affygility Solutions has an occupational exposure limit (OEL) and control band assignment for this active pharmaceutical ingredient (API). This monograph also contains the acceptable daily exposure (ADE) value.

Please note: Due to the complexity and amount of studies regarding this compound—a Natural Health Product—increased cost is charged.

Why do you need this OEL Fastrac monograph?

OEL Fastrac monographs are a cost-effective and convenient way to meet the requirements for PDEs (ADEs) contained in the EMA Guideline on setting health based exposure limits for use in risk identification in the manufacture of different medicinal products in shared facilities (EMA/CHMP/CVMP/SWP/169430/2012), as well as PIC/S and ANVISA requirements, and to obtain the following information:

• The numerical OEL and control band assignment needed to determine the level of required engineering controls and personal protective equipment
• A listing of all cited references utilized in the derivation of the OEL and ADE
• An expert review and discussion with respect to the critical endpoints of concern, the rationale for the choice of endpoints, and dose that is to be used in the derivation of the ADE (PDE), as required by the EMA's Guideline on setting health-based exposure limits for use in risk identification in the manufacture of different medicinal products in shared facilities

Benefits of OEL Fastrac monographs

• Fully documented. Over 20 pages in length, with calculations and cited references.
• Save time! Unsurpassed delivery with instant download.
• Save money. Similar documents cost 5-12 times as much.
• Stay current. Automatic notification of revisions.

How to order

To order an OEL/ADE monograph for Olive Oil, just click the ADD TO CART button.

HBEL

If you're wondering about HBEL, we have something for you.